Hua Quejing Medical has received tens of millions of yuan of exclusive investment from Shenzhen Venture Capital and continues to lead the intelligent development of rehabilitation robots

At the beginning of the new year, the field of rehabilitation robots ushered in heavy financing news.

Arterial Network learned for the first time that Shenzhen Huaquejing Medical Technology Co., Ltd. (hereinafter referred to as "Huaquejing Medical"), a leading international rehabilitation robot company, announced that it recently completed a series A financing of tens of millions of yuan exclusively invested by Shenzhen Venture Capital. The funds raised will be used around the company's vision and mission to scale up the product, marketing and brand building, and continue to consolidate the leading position of product technology.

Founded in July 2019 and headquartered in Shenzhen, Huaquejing Medical is an innovative technology enterprise focusing on intelligent rehabilitation robots and intelligent rehabilitation medical overall solutions. Benefiting from the founding team's more than 15 years of research and development experience and strong technical accumulation in the fields of rehabilitation medicine, medical robots, artificial intelligence, virtual reality, etc., less than 3 years after its establishment, Hua Quejing Medical has passed the national high-tech enterprise certification, and a number of intelligent rehabilitation robots such as upper limbs, fingers, cognition, speech and spine have been developed, and a number of products have been approved NMPA medical device registration certificate; It has more than 70 intellectual property rights such as invention patents at home and abroad.

The intelligent rehabilitation products self-developed by Hua Quejing Medical have also won the first prize of the Chinese Rehabilitation Medical Association, the second prize of the Science and Technology Award of the Chinese Acupuncture and Moxibustion Society, the first prize of the Science and Technology Award of the Guangdong Acupuncture and Moxibustion Society, and the famous high-tech products of Guangdong Province.

The world's first three-dimensional upper limb mirror rehabilitation robot, providing innovative intelligent neurorehabilitation solutions

Based on the self-developed unified architecture of the underlying software and hardware of rehabilitation robots, robot control algorithms, human-computer interaction, intelligent assessment, exoskeleton bionic design, soft robots, virtual reality and sensors, Hua Quejing Medical has developed a series of innovative intelligent rehabilitation robots and rehabilitation equipment, and built a rich product matrix.

There are not only rehabilitation products for hospital specialties, but also rehabilitation products for the community and home, forming a full-cycle systematic intelligent rehabilitation solution for different scene needs, establishing a collaborative relationship between patients, therapists and robots to achieve efficient interaction and emotional integration.

Huaquejing Medical provides full-cycle systematic intelligent rehabilitation solutions

Wisebot®X5 is an exoskeleton rehabilitation robot based on rehabilitation theories such as neuroplasticity and mirror neurons, and is carefully designed for stroke hemiplegia. Hua Quejing Medical Innovation proposed Brunnstrom grading and intelligent assessment technology of joint range of motion, as well as intelligent rehabilitation training program generation technology based on deep learning.

Wisebot®X5 simulates the movement law of human upper limbs in real time in multiple dimensions, not only provides active, passive and active and passive training modes to meet the training needs of different rehabilitation periods, but also pioneers the mirror training mode, which realizes the patient's independent determination of the training action of the affected side, realizes the coordination and synchronous training of both sides of the body, and significantly improves the rehabilitation effect and efficiency.

In addition to significantly improving patients' autonomy and recovery confidence, the mirror training mode of Wisebot®X5 can enable uninjured hemibrains to interact with injured brains, reduce intercortical inhibition, increase the amount of activation of functional areas of the patient's cerebral cortex and expand the activation areas, thereby more effectively promoting brain plasticity changes and functional reorganization, and promoting the functional recovery of damaged areas.

The following video is from

Hua Quejing

Wisebot®X5 not only shows the core technical level of Huaquejing Medical, but also represents the evolution direction of a new generation of rehabilitation robots from a clinical and technical perspective; It is not only another breakthrough in the key core technology in the field of rehabilitation robots in China, but also fills the international gap in the field of rehabilitation robots and provides innovative intelligent neurorehabilitation solutions for hemiplegic patients around the world.

Top composite team,

Innovation potential continues to be strong

The reason why Huaquejing Medical can efficiently translate clinical needs and urgent clinical pain points into engineering language, deeply integrate clinical, technology and products, and launch international first-of-its-kind products with independent core intellectual property rights is inseparable from the strong cross-research and development team of compound medical engineers behind it.

The company's R&D team is composed of first-class rehabilitation medicine, robots and expert teams (academicians, Jieqing, professors, etc.) from the Chinese Academy of Sciences, Harbin Institute of Technology and other universities. Co-founder Dr. Wu Jianhuang is a researcher and doctoral supervisor of the Chinese Academy of Sciences, who has been engaged in the research of surgical robots, computer-assisted medicine and medical transformation for nearly 20 years, and has presided over nearly 20 national, provincial and municipal science and technology plans, and presided over the research and development of vascular interventional surgical robots and other systems. Among the other co-founders, there are senior experts from the rehabilitation industry society, senior experts who have worked in the State Key Laboratory of Robotics and have been engaged in the research and development of medical robots for a long time, sales directors and product directors from well-known medical device groups, and business elites who have successfully created outstanding achievements in the industry and accumulated rich upstream and downstream resources.

On the other hand, since its inception, Huaquejing Medical has followed the logic of medical product research and development of "from the clinic to the clinic", and the scientific research and clinical team led by Academician Chen Lidian, president of the Chinese Association of Rehabilitation Medicine and director of the National and Local Joint Engineering Research Center for Rehabilitation Medical Technology, has continued to have in-depth exchanges and industry-university-research transformation cooperation, and has continuously iterated products according to clinical rigid needs, pain points and feedback, so that products can better provide high-quality services for patients, physicians and institutions.

Aging accelerates the awakening of demand,

Empower the head capital and drive into the fast lane of business

Aging accelerates the awakening of demand, the demand for rehabilitation continues to grow, and rehabilitation has become a key topic of people's livelihood. According to Frost & Sullivan's forecast, the market size of rehabilitation medical devices in China will grow at a compound annual growth rate of about 20%, and the market size will exceed 100 billion in 2025.

On the policy side, China has incorporated rehabilitation into the national development strategy, emphasizing the importance and urgency of developing rehabilitation medicine from the perspective of top-level design. The national "14th Five-Year Plan" medical equipment industry development plan clearly pointed out that the key research is on intelligent rehabilitation robots, exoskeleton rehabilitation robots and other intelligent equipment; The "14th Five-Year Plan" National Health Plan also clearly points out the focus on the development of new health products such as intelligent rehabilitation assistive devices.

Under the awakening of demand, policy support, scale expansion, head capital empowerment, and strong R&D strength, Hua Quejing Medical has started a new journey and entered a commercial outbreak.

Regarding this financing, Dr. Wu Jianhuang, CEO of Huaquejing Medical, said: "We are very grateful to Shenzhen Venture Capital for its recognition and support of Huaquejing Medical's innovation and industrialization capabilities, and especially thank the team of Professor Wang Tianmiao, the last round of investors, for their continuous support and all Huaquejing Medical staff for their unremitting adherence and persistent pursuit of the company's mission and vision. Since its establishment, Huaquejing Medical has adhered to the mission of 'helping people obtain health and happiness', combined with the founding team's more than 15 years of technical accumulation and R&D experience in the field of medical-engineering cross-products, we will continue to develop innovative products that solve the rigid needs and pain points of rehabilitation clinics, help therapists reduce burden and improve rehabilitation efficiency, so that more patients have the opportunity to enjoy intelligent rehabilitation services, and help patients return to society and improve their quality of life as soon as possible. Hua Quejing Medical will always be patient-centered, create value for clinical practice, continuously pursue technology, product and service innovation, actively respond to the call of the country to promote the localization of high-end medical devices, and strive to become a world-class medical technology company with long-term influence. ”

Shenzhen Venture Capital's investment team said: "The report of the 20th National Congress clearly pointed out that the protection of people's health should be given priority to the strategic position of development, and the national strategy of actively coping with the aging of the population should be implemented. Rehabilitation medicine is one of the areas that Shenzhen Venture Capital has long focused on. As a first-class intelligent rehabilitation robot developer in China, the founding team has a deep background in combining medicine and engineering, and has deep insight and understanding of the industry and clinical needs. The company deeply integrates rehabilitation clinical needs, advanced rehabilitation theory, artificial intelligence robot technology, etc., and creatively develops a number of world-leading products to provide patients with precise and intelligent high-quality services. We are pleased to see that the products of Huaquejing Medical not only improve the rehabilitation effect and efficiency, but also improve the quality of life of patients. We are pleased to be able to cooperate with a team with continuous creativity and efficient execution like Hua Quejing Medical, and we will continue to carry out in-depth cooperation with Hua Quejing Medical in multiple dimensions with the help of the industry experience and resources accumulated by Shenzhen Venture Capital, provide all-round support for patients and people to bring more high-value products and services, and work together to promote the development of China's intelligent rehabilitation cause and contribute to the construction of a healthy China." ”

About Shenzhen Venture Capital

Shenzhen Innovation Investment Group Co., Ltd. (hereinafter referred to as "Shenzhen Venture Capital"), funded by Shenzhen Municipal Government in 1999 and guided by social capital to set up, the company to discover and achieve great enterprises as the mission, is committed to being the explorer and cultivator of innovative value, has developed into a venture capital as the core of comprehensive investment group, now registered capital of 10 billion yuan, the total scale of various types of funds under management is about 433.4 billion yuan. The company adheres to the concept of "three points of investment, seven points of service", and promotes the rapid and healthy development of investment enterprises through resource integration, capital operation, supervision and standardization, training and counseling. As of December 2022, Shenzhen Venture Capital has led the industry in the number of listings, with a total of 239 investment companies listed in 17 capital markets around the world. With its outstanding performance in the field of venture capital, Shenzhen Venture Capital has been ranked among the best in the comprehensive ranking of venture capital institutions organized by China Venture Capital Commission, Qingke Group, Investment China Group and other authoritative institutions for many consecutive years. From 2016 to 2022, in the annual selection of Qingke China venture capital institutions, Shenzhen Venture Capital ranked first among local venture capital institutions.